Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121110713 | 12111071 | 3 | F | 20160818 | 20160224 | 20160829 | EXP | CA-PFIZER INC-2016052445 | PFIZER | 44.00 | YR | M | Y | 0.00000 | 20160829 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121110713 | 12111071 | 1 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, WEEKLY | 0 | 50 | MG | /wk | |||||||
121110713 | 12111071 | 2 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | 20 MG, WEEKLY | 11719 | 20 | MG | /wk | |||||||
121110713 | 12111071 | 3 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | UNK, UNK (INJECTABLE) | 11719 | |||||||||||
121110713 | 12111071 | 4 | SS | CELEBREX | CELECOXIB | 1 | Oral | UNK | 20998 | CAPSULE, HARD | |||||||||
121110713 | 12111071 | 5 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 1 G, 2X/DAY | 7073 | 1 | G | BID | |||||||
121110713 | 12111071 | 6 | SS | REMICADE | INFLIXIMAB | 1 | 3 MG/KG, EVERY 8 WEEKS | 0 | 3 | MG/KG | |||||||||
121110713 | 12111071 | 7 | SS | ORENCIA | ABATACEPT | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
121110713 | 12111071 | 8 | SS | ORENCIA | ABATACEPT | 1 | Subcutaneous | UNK | 0 | ||||||||||
121110713 | 12111071 | 9 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | 400 MG, 1X/DAY | 0 | 400 | MG | TABLET | QD | |||||||
121110713 | 12111071 | 10 | C | PREDNISONE. | PREDNISONE | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
121110713 | 12111071 | 2 | Rheumatoid arthritis |
121110713 | 12111071 | 4 | Rheumatoid arthritis |
121110713 | 12111071 | 10 | Arthritis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
121110713 | 12111071 | HO |
121110713 | 12111071 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
121110713 | 12111071 | Abdominal discomfort | |
121110713 | 12111071 | Drug ineffective | |
121110713 | 12111071 | Drug intolerance | |
121110713 | 12111071 | Respiratory arrest | |
121110713 | 12111071 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |